| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36767049777ba4c08df66745f8c99645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9ce04c0f53b09eaf86c15a28d47be6df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e939590c2c9c56f2cd8fecb38bea313 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_248669d71b5d3d0996be73b1ec5dd85b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bfcd844dff16c6358f59125ba6e8644 |
| publicationDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009034136-A2 |
| titleOfInvention |
Pharmaceutical compound |
| abstract |
Provided is a compound comprising: (a) a first component capable of binding to ER+ cell receptors; and (b) a second component; wherein the second component is a ribosome inactivating toxin and is conjugated to the first component. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8158614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010088203-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889101-B2 |
| priorityDate |
2007-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |